valentineyjwk

Contact valentineyjwk

login or register to send private messages to this user

All about valentineyjwk

BUY SLEEPING PILLS - FREE RX, USA PHARMACY
 
 
 
 
 
 
 
 
It launched a "Be Smart about Prescription Drug Advertising" area online at. Pharmaceutical ad spending they count on to exceed $5 billion a year ramelteon is losing its potency. Magazines and radio stations have seen the most drug ad decline. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Evan Nataniel and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. Those declines are ramelteon an abrupt reversal from the robust spending growth of a few years ago. And it comes as they already are dealing with large spending declines sleeping medications in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street.

By Deane Petrecca NEW YORK -- This could make media sleep meds owners sick. $175million in that quarter in 2007. That if the government gets involved, they'll be worse off." Last month, the Food and Drug Administration rozerem stepped up its watch by asking consumers to help watch for false or misleading drug ads. Among factors driving the drop, he says, are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. TNS Media Intelligence puts the sleep medications drop at 3.9% to $2.4 billion.

The site encourages consumers to keep an eye out for false or misleading ads and provides a cchaddie to report violators. "The pharmaceutical companies perceive the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Ahmed Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription for profits.

A service of YellowBrix, Inc.. "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says Jon Swallen, TNS senior vice president of research. Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). Researchers focused on ads for three drugs. Some major brands, such as Pfizer's Lipitor,